Van Cleef Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.56M | Sell |
2,786
-40
| -1% | -$40.6K | 0.28% | 41 |
|
|
2025
Q4 | $3.04M | Buy |
2,826
+55
| +2% | +$52.6K | 0.31% | 39 |
|
|
2025
Q3 | $2.11M | Sell |
2,771
-15
| -0.5% | -$11.2K | 0.21% | 45 |
|
|
2025
Q2 | $2.17M | Sell |
2,786
-610
| -18% | -$474K | 0.23% | 42 |
|
|
2025
Q1 | $2.81M | Hold |
3,396
| – | – | 0.32% | 39 |
|
|
2024
Q4 | $2.62M | Sell |
3,396
-215
| -6% | -$178K | 0.29% | 42 |
|
|
2024
Q3 | $3.2M | Hold |
3,611
| – | – | 0.36% | 41 |
|
|
2024
Q2 | $3.27M | Sell |
3,611
-20
| -0.6% | -$16K | 0.41% | 35 |
|
|
2024
Q1 | $2.82M | Sell |
3,631
-45
| -1% | -$32K | 0.36% | 38 |
|
|
2023
Q4 | $2.14M | Buy |
3,676
+575
| +19% | +$336K | 0.3% | 45 |
|
|
2023
Q3 | $1.67M | Sell |
3,101
-37
| -1% | -$19.1K | 0.26% | 48 |
|
|
2023
Q2 | $1.47M | Sell |
3,138
-75
| -2% | -$31.5K | 0.23% | 50 |
|
|
2023
Q1 | $1.1M | Sell |
3,213
-30
| -0.9% | -$10.1K | 0.17% | 56 |
|
|
2022
Q4 | $1.19M | Buy |
3,243
+491
| +18% | +$174K | 0.2% | 54 |
|
|
2022
Q3 | $890K | Sell |
2,752
-75
| -3% | -$23.8K | 0.17% | 56 |
|
|
2022
Q2 | $917K | Sell |
2,827
-75
| -3% | -$22.5K | 0.16% | 55 |
|
|
2022
Q1 | $831K | Buy |
2,902
+1
| +0% | +$257 | 0.12% | 64 |
|
|
2021
Q4 | $801K | Sell |
2,901
-149
| -5% | -$37.8K | 0.11% | 65 |
|
|
2021
Q3 | $705K | Sell |
3,050
-58
| -2% | -$14.3K | 0.11% | 69 |
|
|
2021
Q2 | $713K | Sell |
3,108
-250
| -7% | -$50.2K | 0.11% | 74 |
|
|
2021
Q1 | $627K | Sell |
3,358
-700
| -17% | -$137K | 0.1% | 77 |
|
|
2020
Q4 | $685K | Buy |
4,058
+1
| +0% | +$149 | 0.11% | 69 |
|
|
2020
Q3 | $601K | Sell |
4,057
-374
| -8% | -$57.9K | 0.11% | 73 |
|
|
2020
Q2 | $728K | Sell |
4,431
-2,905
| -40% | -$446K | 0.15% | 62 |
|
|
2020
Q1 | $1.02M | Buy |
7,336
+1
| +0% | +$137 | 0.25% | 50 |
|
|
2019
Q4 | $964K | Sell |
7,335
-99
| -1% | -$11.5K | 0.2% | 64 |
|
|
2019
Q3 | $831K | Sell |
7,434
-74
| -1% | -$8.24K | 0.18% | 64 |
|
|
2019
Q2 | $832K | Sell |
7,508
-100
| -1% | -$11.8K | 0.18% | 65 |
|
|
2019
Q1 | $987K | Buy |
7,608
+1,941
| +34% | +$236K | 0.23% | 55 |
|
|
2018
Q4 | $656K | Sell |
5,667
-200
| -3% | -$22.3K | 0.18% | 68 |
|
|
2018
Q3 | $630K | Buy |
5,867
+1
| +0% | +$100 | 0.14% | 68 |
|
|
2018
Q2 | $501K | Buy |
5,866
+760
| +15% | +$62.4K | 0.12% | 74 |
|
|
2018
Q1 | $395K | Sell |
5,106
-49
| -1% | -$3.94K | 0.1% | 84 |
|
|
2017
Q4 | $435K | Buy |
+5,155
| New | +$439K | 0.11% | 85 |
|
|
2016
Q2 | – | Sell |
-3,190
| Closed | -$230K | – | 102 |
|
|
2016
Q1 | $230K | Sell |
3,190
-27
| -0.8% | -$2.04K | 0.08% | 90 |
|
|
2015
Q4 | $271K | Buy |
3,217
+316
| +11% | +$26.2K | 0.1% | 89 |
|
|
2015
Q3 | $243K | Buy |
+2,901
| New | +$245K | 0.1% | 89 |
|
Other funds holding LLY
VCM
VPM
Van Cleef Asset Management's LLY Position: Q1 2026 in Review
Van Cleef Asset Management reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $40.6K and leaving 2,786 shares worth $2.56M. The position accounts for 0.28% of the portfolio, ranked #41.
Van Cleef Asset Management first reported a position in LLY in Q3 2015 and has held it in 37 quarters since. The position peaked at $3.27M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Van Cleef Asset Management held 2,786 shares of Eli Lilly worth $2.56M as of Q1 2026.
- Van Cleef Asset Management sold 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.28% of Van Cleef Asset Management's portfolio in Q1 2026, its #41 holding.
- Van Cleef Asset Management first reported a position in Eli Lilly in Q3 2015 and has held it in 37 quarters since.
- Van Cleef Asset Management's Eli Lilly position peaked at $3.27M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.